
How to Use Aspaveli (Pegcetacoplan) Safely: A Complete Patient Handbook
Introduction Aspaveli (pegcetacoplan) is a C3 complement inhibitor used for the treatment of paroxysmal nocturnal…

Introduction Aspaveli (pegcetacoplan) is a C3 complement inhibitor used for the treatment of paroxysmal nocturnal…

April 2023 – The U.S. Food and Drug Administration (FDA) today approved Qalsody (tofersen) for…

China’s National Drug Administration (NMPA) has officially approved the marketing application for the novel anti-hepatitis…

Recently, the U.S. Food and Drug Administration (FDA) announced the accelerated approval of Jaypirca (generic…

In this blog, DengYue will explore the following aspects of Alkindi Hydrocortisone: Advantages over traditional…

In October 2018, the U.S. Food and Drug Administration (FDA) approved talazoparib, a novel PARP…

In October 2021, the U.S. Food and Drug Administration (FDA) approved a novel drug, Tavneos…

What is Agamree (Vamorolone)? Agamree Vamorolone, also known by its generic name Vamorolone, is a…

Garsorasib Company Today announced a significant milestone in the development of its flagship drug, Garsorasib, a…

Introduction Cidofovir is an antiviral medication primarily used to treat cytomegalovirus (CMV) retinitis in patients…